Long et al. conducted in vitro experiments, which demonstrated that the upregulation of IL-35 impeded the proliferation of diverse human tumor cells, triggered cell cycle arrest in the G1 phase, and facilitated apoptosis through the upregulation of Fas expression and downregulation of cyclinD1, survivin, and Bcl-2 expression [131]. The gene discussed is BCL2; the disease is neoplasm.